Decreased intramuscular calcium hydroxyapatite implant resorption in a murine model of osteoporosis

Derrick R. Randall, Nogah Nativ-Zeltzer, Daniel Cates, Steve P. Tinling, Peter C Belafsky

Research output: Contribution to journalArticle

Abstract

Objective: Calcium hydroxyapatite (CaHA) is a common material for vocal fold injection augmentation. Durability is variable, and factors involved in implant longevity are not understood. Animal models of osteoporosis show decreased bone density and increased mineral liberation, suggesting CaHA retention may be altered in these conditions. Study Design: Prospective murine investigation. Methods: Fourteen skeletally mature, 10-month-old female Sprague-Dewley rats were treated by one of three interventions: oophorectomy, laparotomy without oophorectomy (sham), or monthly risedronate injection (90 μg/kg, subcutaneous). CaHA was implanted into the right lateral thigh muscle in all animals at the time of procedure or first risedronate injection. After 17 weeks, all rats were sacrificed, and the residual CaHA isolated from excised lateral thigh muscle through incubation in a 900 °C calcinator for 9 hours. Results: Mean CaHA mass remaining in the oophorectomy group was 65.9 (standard deviation ± 16.1) mg, compared to 44.4 ± 10.0 mg CaHA in the risedronate group and 48.6 ± 7.5 mg in the sham group. One-way analysis of variance found a statistically significant difference between the oophorectomy and risedronate groups but not between the sham and other groups, F(2,11) = 4.404, P = 0.039. Conclusion: Persistent estrogen deficiency in a murine model of osteoporosis demonstrated decreased rate of CaHA resorption. This suggests that hormone alterations associated with osteoporosis may alter the longevity of CaHA implant resorption through an uncertain mechanism. Level of Evidence: NA. Laryngoscope, 2018.

Original languageEnglish (US)
JournalLaryngoscope
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Durapatite
Osteoporosis
Ovariectomy
Thigh
Injections
Laryngoscopes
Muscles
Vocal Cords
Bone Density
Laparotomy
Analysis of Variance
Estrogens
Animal Models
Hormones
Prospective Studies
Risedronate Sodium

Keywords

  • calcium hydroxyapatite
  • laryngology
  • Vocal fold augmentation
  • vocal fold paralysis
  • voice

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Decreased intramuscular calcium hydroxyapatite implant resorption in a murine model of osteoporosis. / Randall, Derrick R.; Nativ-Zeltzer, Nogah; Cates, Daniel; Tinling, Steve P.; Belafsky, Peter C.

In: Laryngoscope, 01.01.2018.

Research output: Contribution to journalArticle

@article{f0329ae7c6264147832b5ea1690a48ff,
title = "Decreased intramuscular calcium hydroxyapatite implant resorption in a murine model of osteoporosis",
abstract = "Objective: Calcium hydroxyapatite (CaHA) is a common material for vocal fold injection augmentation. Durability is variable, and factors involved in implant longevity are not understood. Animal models of osteoporosis show decreased bone density and increased mineral liberation, suggesting CaHA retention may be altered in these conditions. Study Design: Prospective murine investigation. Methods: Fourteen skeletally mature, 10-month-old female Sprague-Dewley rats were treated by one of three interventions: oophorectomy, laparotomy without oophorectomy (sham), or monthly risedronate injection (90 μg/kg, subcutaneous). CaHA was implanted into the right lateral thigh muscle in all animals at the time of procedure or first risedronate injection. After 17 weeks, all rats were sacrificed, and the residual CaHA isolated from excised lateral thigh muscle through incubation in a 900 °C calcinator for 9 hours. Results: Mean CaHA mass remaining in the oophorectomy group was 65.9 (standard deviation ± 16.1) mg, compared to 44.4 ± 10.0 mg CaHA in the risedronate group and 48.6 ± 7.5 mg in the sham group. One-way analysis of variance found a statistically significant difference between the oophorectomy and risedronate groups but not between the sham and other groups, F(2,11) = 4.404, P = 0.039. Conclusion: Persistent estrogen deficiency in a murine model of osteoporosis demonstrated decreased rate of CaHA resorption. This suggests that hormone alterations associated with osteoporosis may alter the longevity of CaHA implant resorption through an uncertain mechanism. Level of Evidence: NA. Laryngoscope, 2018.",
keywords = "calcium hydroxyapatite, laryngology, Vocal fold augmentation, vocal fold paralysis, voice",
author = "Randall, {Derrick R.} and Nogah Nativ-Zeltzer and Daniel Cates and Tinling, {Steve P.} and Belafsky, {Peter C}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/lary.27348",
language = "English (US)",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Decreased intramuscular calcium hydroxyapatite implant resorption in a murine model of osteoporosis

AU - Randall, Derrick R.

AU - Nativ-Zeltzer, Nogah

AU - Cates, Daniel

AU - Tinling, Steve P.

AU - Belafsky, Peter C

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Calcium hydroxyapatite (CaHA) is a common material for vocal fold injection augmentation. Durability is variable, and factors involved in implant longevity are not understood. Animal models of osteoporosis show decreased bone density and increased mineral liberation, suggesting CaHA retention may be altered in these conditions. Study Design: Prospective murine investigation. Methods: Fourteen skeletally mature, 10-month-old female Sprague-Dewley rats were treated by one of three interventions: oophorectomy, laparotomy without oophorectomy (sham), or monthly risedronate injection (90 μg/kg, subcutaneous). CaHA was implanted into the right lateral thigh muscle in all animals at the time of procedure or first risedronate injection. After 17 weeks, all rats were sacrificed, and the residual CaHA isolated from excised lateral thigh muscle through incubation in a 900 °C calcinator for 9 hours. Results: Mean CaHA mass remaining in the oophorectomy group was 65.9 (standard deviation ± 16.1) mg, compared to 44.4 ± 10.0 mg CaHA in the risedronate group and 48.6 ± 7.5 mg in the sham group. One-way analysis of variance found a statistically significant difference between the oophorectomy and risedronate groups but not between the sham and other groups, F(2,11) = 4.404, P = 0.039. Conclusion: Persistent estrogen deficiency in a murine model of osteoporosis demonstrated decreased rate of CaHA resorption. This suggests that hormone alterations associated with osteoporosis may alter the longevity of CaHA implant resorption through an uncertain mechanism. Level of Evidence: NA. Laryngoscope, 2018.

AB - Objective: Calcium hydroxyapatite (CaHA) is a common material for vocal fold injection augmentation. Durability is variable, and factors involved in implant longevity are not understood. Animal models of osteoporosis show decreased bone density and increased mineral liberation, suggesting CaHA retention may be altered in these conditions. Study Design: Prospective murine investigation. Methods: Fourteen skeletally mature, 10-month-old female Sprague-Dewley rats were treated by one of three interventions: oophorectomy, laparotomy without oophorectomy (sham), or monthly risedronate injection (90 μg/kg, subcutaneous). CaHA was implanted into the right lateral thigh muscle in all animals at the time of procedure or first risedronate injection. After 17 weeks, all rats were sacrificed, and the residual CaHA isolated from excised lateral thigh muscle through incubation in a 900 °C calcinator for 9 hours. Results: Mean CaHA mass remaining in the oophorectomy group was 65.9 (standard deviation ± 16.1) mg, compared to 44.4 ± 10.0 mg CaHA in the risedronate group and 48.6 ± 7.5 mg in the sham group. One-way analysis of variance found a statistically significant difference between the oophorectomy and risedronate groups but not between the sham and other groups, F(2,11) = 4.404, P = 0.039. Conclusion: Persistent estrogen deficiency in a murine model of osteoporosis demonstrated decreased rate of CaHA resorption. This suggests that hormone alterations associated with osteoporosis may alter the longevity of CaHA implant resorption through an uncertain mechanism. Level of Evidence: NA. Laryngoscope, 2018.

KW - calcium hydroxyapatite

KW - laryngology

KW - Vocal fold augmentation

KW - vocal fold paralysis

KW - voice

UR - http://www.scopus.com/inward/record.url?scp=85053249968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053249968&partnerID=8YFLogxK

U2 - 10.1002/lary.27348

DO - 10.1002/lary.27348

M3 - Article

C2 - 30194683

AN - SCOPUS:85053249968

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

ER -